Evidence map›Paper›PMID 26439909›Full record

ArticleClinical and experimental immunology2016

Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells.

E Townsley, G O'Connor, C Cosgrove, M Woda, M Co, S J Thomas, S Kalayanarooj, I-K Yoon, A Nisalak, A Srikiatkhachorn and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Dengue virus and the host innate immune response.Emerging microbes & infections · 2018
    Review
  17. Host genetic control of mosquito-borne Flavivirus infections.Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Review
  18. Review
  19. Upregulation of HLA-E by dengue and not Zika viruses.Clinical & translational immunology · 2018
    Article
  20. Stable Frequencies of HLA-CFrontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

E TownsleyDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
G O'ConnorCancer and Inflammation Program, Laboratory of Experimental Immunology, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
C CosgroveRagon Institute at MGH, MIT And Harvard, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
M WodaDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
M CoDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
S J ThomasWalter Reed Army Institute of Research, Silver Spring, MD, USA.
S KalayanaroojQueen Sirikit National Institute for Child Health, Bangkok, Thailand.
I-K YoonDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
A NisalakDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
A SrikiatkhachornDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
S GreenDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
H A F StephensCentre for Nephrology and the Anthony Nolan Trust, Royal Free Campus, University College, London, UK.
E GostickCardiff University School of Medicine, Institute of Infection and Immunity, Cardiff, UK.
D A PriceCardiff University School of Medicine, Institute of Infection and Immunity, Cardiff, UK.
M CarringtonCancer and Inflammation Program, Laboratory of Experimental Immunology, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
G AlterRagon Institute at MGH, MIT And Harvard, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
D W McVicarCancer and Inflammation Program, Laboratory of Experimental Immunology, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
A L RothmanInstitute for Immunology and Informatics, University of Rhode Island, Providence, RI, USA.
A MathewDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
University of Massachusetts Chan Medical School · USLeidos (United States) · USArmed Forces Research Institute of Medical Science · THCardiff University · GBAnthony Nolan · GBHarvard University · USQueen Sirikit National Institute of Child Health · THRagon Institute of MGH, MIT and Harvard · USUniversity of Rhode Island · USWalter Reed Army Institute of Research · US

Funding

VIRAL DETERMINANTS OF SEVERE DENGUE DISEASEP01AI034533 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ROTHMAN, ALAN L · 1994 to 2022
$42.0M
Technologies for Human Cellular ImmunologyU19AI057319 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIBRATY, DANIEL H. · 2003 to 2013
$34.4M
Effects of genetic polymorphism in MHC, KIR, and related loci on human diseaseZIABC010791 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CARRINGTON, MARY N. · 2009 to 2025
$18.2M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
Medical Scientist Training at UMMS Administrative SupplementT32GM107000 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIEFE, CATARINA I. · 2013 to 2022
$4.9M
NK cell regulation of immune responses to dengueR21AI113479 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MATHEW, ANUJA · 2015 to 2016
$425k
CCR NIH HHS HHSN261200800001CIntramural NIH HHSNCI NIH HHS HHSN261200800001ENIAID NIH HHS P01 AI034533NIAID NIH HHS P01AI34533NIAID NIH HHS R21 AI113479NIAID NIH HHS U19 AI057319NIAID NIH HHS U19 AI57319NIDDK NIH HHS NIH P30 DK032520NIDDK NIH HHS P30 DK032520NIGMS NIH HHS T32 GM107000Wellcome Trust 100326
6 · The paper itself

Abstract

Killer immunoglobulin-like receptors (KIRs) interact with human leucocyte antigen (HLA) class I ligands and play a key role in the regulation and activation of NK cells. The functional importance of KIR-HLA interactions has been demonstrated for a number of chronic viral infections, but to date only a few studies have been performed in the context of acute self-limited viral infections. During our investigation of CD8(+) T cell responses to a conserved HLA-B57-restricted epitope derived from dengue virus (DENV) non-structural protein-1 (NS1), we observed substantial binding of the tetrameric complex to non-T/non-B lymphocytes in peripheral blood mononuclear cells (PBMC) from a long-standing clinical cohort in Thailand. We confirmed binding of the NS1 tetramer to CD56(dim) NK cells, which are known to express KIRs. Using depletion studies and KIR-transfected cell lines, we demonstrated further that the NS1 tetramer bound the inhibitory receptor KIR3DL1. Phenotypical analysis of PBMC from HLA-B57(+) subjects with acute DENV infection revealed marked activation of NS1 tetramer-binding natural killer (NK) cells around the time of defervescence in subjects with severe dengue disease. Collectively, our findings indicate that subsets of NK cells are activated relatively late in the course of acute DENV illness and reveal a possible role for specific KIR-HLA interactions in the modulation of disease outcomes.

Indexed as

Acute DiseaseAdolescentChildChild, PreschoolDengueDengue VirusEpitopes, T-LymphocyteFemaleHLA-B AntigensHumansInfantKiller Cells, NaturalLeukocytes, MononuclearMalePeptide FragmentsProtein BindingEpitopes, T-LymphocyteHLA-B57 antigenHLA-B AntigensPeptide FragmentsReceptors, KIR3DL1Viral Nonstructural ProteinsdengueHLAKIRNKpathogenesis

Identifiers

PMID26439909
PMCPMC4750593
OpenAlexW1846244336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.